These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33025735)

  • 1. Gold Drugs with {Au(PPh
    Stenger-Smith JR; Mascharak PK
    ChemMedChem; 2020 Nov; 15(22):2136-2145. PubMed ID: 33025735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical biology of anticancer gold(III) and gold(I) complexes.
    Zou T; Lum CT; Lok CN; Zhang JJ; Che CM
    Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new gold(I) complex-Au(PPh
    Li X; Huang Q; Long H; Zhang P; Su H; Liu J
    EBioMedicine; 2019 Jan; 39():159-172. PubMed ID: 30527624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold(III) complexes in medicinal chemistry.
    Maia PI; Deflon VM; Abram U
    Future Med Chem; 2014 Sep; 6(13):1515-36. PubMed ID: 25365235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
    Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
    Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Gold Candidates against Human Colon Cancer.
    Abbasi M; Yaqoob M; Haque RA; Iqbal MA
    Mini Rev Med Chem; 2021; 21(1):69-78. PubMed ID: 32767935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the biological evaluation of gold anticancer agents.
    Fricker SP
    Anticancer Agents Med Chem; 2011 Dec; 11(10):940-52. PubMed ID: 21864236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action.
    Lima JC; Rodriguez L
    Anticancer Agents Med Chem; 2011 Dec; 11(10):921-8. PubMed ID: 21864238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
    Li CK; Sun RW; Kui SC; Zhu N; Che CM
    Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
    Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
    Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
    Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold(III) Complexes for Antitumor Applications: An Overview.
    Bertrand B; Williams MRM; Bochmann M
    Chemistry; 2018 Aug; 24(46):11840-11851. PubMed ID: 29575433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs.
    de Andrade Querino AL; de Sousa AM; Thomas SR; de Lima GM; Dittz D; Casini A; do Monte-Neto RL; Silva H
    J Inorg Biochem; 2023 Oct; 247():112346. PubMed ID: 37536162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteronuclear gold(I)-silver(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines.
    Barreiro E; Casas JS; Couce MD; Sánchez A; Sordo J; Vázquez-López EM
    J Inorg Biochem; 2014 Feb; 131():68-75. PubMed ID: 24269769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
    Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
    Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal Au(I) compounds targeting urease as prospective antimicrobial agents: unveiling the structural basis for enzyme inhibition.
    Mazzei L; Massai L; Cianci M; Messori L; Ciurli S
    Dalton Trans; 2021 Oct; 50(40):14444-14452. PubMed ID: 34585201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Mercaptopurine complexes with silver and gold ions: anti-tuberculosis and anti-cancer activities.
    Cuin A; Massabni AC; Pereira GA; Leite CQ; Pavan FR; Sesti-Costa R; Heinrich TA; Costa-Neto CM
    Biomed Pharmacother; 2011 Aug; 65(5):334-8. PubMed ID: 21775091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Aminophosphane)gold(I) and silver(I) complexes as antibacterial agents.
    Ortego L; Gonzalo-Asensio J; Laguna A; Villacampa MD; Gimeno MC
    J Inorg Biochem; 2015 May; 146():19-27. PubMed ID: 25706322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effect and mechanism of a Se-modified porphyrin Au(III) complex.
    Yang FR; Li Y; Zhang XH; Wang M; Guo HR; Ruan WJ
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3592-6. PubMed ID: 26152428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.